Abstract 6255: Patient response to immune checkpoint inhibitors (ICI) informs neoantigen prioritization: Applications to personalized cancer vaccines (PCVs) and ICI response prediction
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Natera (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409629507
